Co-Diagnostics, Inc.

Co-Diagnostics, Inc. (NASDAQ: CODX)
Johnson Fistel, LLP is investigating potential claims on behalf of Co-Diagnostics, Inc. (“Co-Dx” or the “Company”) (NASDAQ: CODX) against certain of its officers and directors.

If you have continuously owned Co-Dx shares since May 12, 2022, submit your information below:

The complaint alleges that, during the Class Period, Defendants repeatedly touted the Logix Smart™ COVID-19 Test, reassuring investors about the demand for the product.  At the same time, Defendants failed to disclose that: (1) demand for the Logix Smart™ COVID19 Test had plummeted throughout the quarter ended June 30, 2022, and (2) as a result, Defendants’ positive statements about the demand for the Logix Smart™ COVID-19 Test lacked a reasonable basis.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. Johnson Fistel seeks to recover losses incurred due to violations of federal securities laws. For more information about the firm and its attorneys, please visit Attorney advertising. Past results do not guarantee future outcomes.

Johnson Fistel, LLP
Jim Baker, Lead Securities Analyst
Telephone: (619) 814-4471